Bloomberg Daybreak: Europe Edition cover image

Tariff Plans Still In Limbo, Markets Hold Their Breath & Big Pharma Fears

Bloomberg Daybreak: Europe Edition

00:00

Restructuring of a Health Agency: Implications for Drug Approvals

This chapter explores the major changes within a health agency, focusing on the dismissal of top officials and the layoff of around 10,000 employees. It emphasizes the potential impact on the pharmaceutical industry and raises concerns about the FDA's future role in drug approvals amid the restructuring.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app